Cargando…
TUSC3 Loss Alters the ER Stress Response and Accelerates Prostate Cancer Growth in vivo
Prostate cancer is the most prevalent cancer in males in developed countries. Tumor suppressor candidate 3 (TUSC3) has been identified as a putative tumor suppressor gene in prostate cancer, though its function has not been characterized. TUSC3 shares homologies with the yeast oligosaccharyltransfer...
Autores principales: | Horak, Peter, Tomasich, Erwin, Vaňhara, Petr, Kratochvílová, Kateřina, Anees, Mariam, Marhold, Maximilian, Lemberger, Christof E., Gerschpacher, Marion, Horvat, Reinhard, Sibilia, Maria, Pils, Dietmar, Krainer, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894551/ https://www.ncbi.nlm.nih.gov/pubmed/24435307 http://dx.doi.org/10.1038/srep03739 |
Ejemplares similares
-
MALAT1 Fusions and Basal Cells Contribute to Primary Resistance against Androgen Receptor Inhibition in TRAMP Mice
por: Marhold, Maximilian, et al.
Publicado: (2022) -
Synthetic lethal combinations of low-toxicity drugs for breast cancer identified in silico by genetic screens in yeast
por: Marhold, Maximilian, et al.
Publicado: (2018) -
Synthetic lethality guiding selection of drug combinations in ovarian cancer
por: Heinzel, Andreas, et al.
Publicado: (2019) -
Immune checkpoint inhibitors in mCRPC - rationales, challenges and perspectives
por: Taghizadeh, H., et al.
Publicado: (2019) -
Circulating Endothelial Progenitor Cells in Castration Resistant Prostate Cancer: A Randomized, Controlled, Biomarker Study
por: Fuereder, Thorsten, et al.
Publicado: (2014)